These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22136053)

  • 1. In vitro cytokine release assays: reducing the risk of adverse events in man.
    Kirton CM; Gliddon DR; Bannish G; Bembridge GP; Coney LA
    Bioanalysis; 2011 Dec; 3(23):2657-63. PubMed ID: 22136053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A whole blood in vitro cytokine release assay with aqueous monoclonal antibody presentation for the prediction of therapeutic protein induced cytokine release syndrome in humans.
    Wolf B; Morgan H; Krieg J; Gani Z; Milicov A; Warncke M; Brennan F; Jones S; Sims J; Kiessling A
    Cytokine; 2012 Dec; 60(3):828-37. PubMed ID: 22986013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials--Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm.
    Vessillier S; Eastwood D; Fox B; Sathish J; Sethu S; Dougall T; Thorpe SJ; Thorpe R; Stebbings R
    J Immunol Methods; 2015 Sep; 424():43-52. PubMed ID: 25960173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A predictive biomimetic model of cytokine release induced by TGN1412 and other therapeutic monoclonal antibodies.
    Dhir V; Fort M; Mahmood A; Higbee R; Warren W; Narayanan P; Wittman V
    J Immunotoxicol; 2012; 9(1):34-42. PubMed ID: 22074378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody first dose cytokine release syndromes-mechanisms and prediction.
    Wing M
    J Immunotoxicol; 2008 Jan; 5(1):11-5. PubMed ID: 18382853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release.
    Eastwood D; Bird C; Dilger P; Hockley J; Findlay L; Poole S; Thorpe SJ; Wadhwa M; Thorpe R; Stebbings R
    Br J Clin Pharmacol; 2013 Aug; 76(2):299-315. PubMed ID: 23701319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. After TGN1412: recent developments in cytokine release assays.
    Stebbings R; Eastwood D; Poole S; Thorpe R
    J Immunotoxicol; 2013; 10(1):75-82. PubMed ID: 22967038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.
    Suntharalingam G; Perry MR; Ward S; Brett SJ; Castello-Cortes A; Brunner MD; Panoskaltsis N
    N Engl J Med; 2006 Sep; 355(10):1018-28. PubMed ID: 16908486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of biologics, lessons learnt from TGN1412.
    Stebbings R; Poole S; Thorpe R
    Curr Opin Biotechnol; 2009 Dec; 20(6):673-7. PubMed ID: 19892543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cells co-stimulate peripheral blood mononuclear cell responses to monoclonal antibody TGN1412 in culture.
    Findlay L; Sharp G; Fox B; Ball C; Robinson CJ; Bird C; Stebbings R; Eastwood D; Wadhwa M; Poole S; Thorpe R; Thorpe SJ
    Cytokine; 2011 Jul; 55(1):141-51. PubMed ID: 21493088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal human whole blood in motion, as a tool to predict first-infusion reactions and mechanism-of-action of immunotherapeutics.
    Fletcher EAK; Eltahir M; Lindqvist F; Rieth J; Törnqvist G; Leja-Jarblad J; Mangsbo SM
    Int Immunopharmacol; 2018 Jan; 54():1-11. PubMed ID: 29100032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics.
    Stebbings R; Findlay L; Edwards C; Eastwood D; Bird C; North D; Mistry Y; Dilger P; Liefooghe E; Cludts I; Fox B; Tarrant G; Robinson J; Meager T; Dolman C; Thorpe SJ; Bristow A; Wadhwa M; Thorpe R; Poole S
    J Immunol; 2007 Sep; 179(5):3325-31. PubMed ID: 17709549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of multi-organic failure in autoimmune diseases.
    Amaral MC; Alves JD
    Autoimmun Rev; 2009 May; 8(6):525-8. PubMed ID: 19186222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of novel methods for predicting the risk of pro-inflammatory clinical infusion reactions during monoclonal antibody therapy.
    Findlay L; Eastwood D; Ball C; Robinson CJ; Bird C; Wadhwa M; Thorpe SJ; Thorpe R; Stebbings R; Poole S
    J Immunol Methods; 2011 Aug; 371(1-2):134-42. PubMed ID: 21741383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primate testing of TGN1412: right target, wrong cell.
    Pallardy M; Hünig T
    Br J Pharmacol; 2010 Oct; 161(3):509-11. PubMed ID: 20880391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a human whole blood assay for prediction of cytokine release similar to anti-CD28 superagonists using multiplex cytokine and hierarchical cluster analysis.
    Walker MR; Makropoulos DA; Achuthanandam R; Van Arsdell S; Bugelski PJ
    Int Immunopharmacol; 2011 Nov; 11(11):1697-705. PubMed ID: 21689786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-release syndrome: overview and nursing implications.
    Breslin S
    Clin J Oncol Nurs; 2007 Feb; 11(1 Suppl):37-42. PubMed ID: 17471824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine release assays: current practices and future directions.
    Finco D; Grimaldi C; Fort M; Walker M; Kiessling A; Wolf B; Salcedo T; Faggioni R; Schneider A; Ibraghimov A; Scesney S; Serna D; Prell R; Stebbings R; Narayanan PK
    Cytokine; 2014 Apr; 66(2):143-55. PubMed ID: 24412476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.